A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

Cell ther­a­py biotech Reg­Cell is hop­ing to bridge sci­ence from Japan with the US biotech in­dus­try to de­vel­op new cell ther­a­pies for au­toim­mune con­di­tions.

Read more here